Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-017126
Filing Date
2013-03-25
Accepted
2013-03-25 10:21:50
Documents
21
Period of Report
2013-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v338961_6k.htm 6-K 4721121
2 GRAPHIC tfooter.jpg GRAPHIC 8179
3 GRAPHIC theader.jpg GRAPHIC 8511
4 GRAPHIC tlogo.jpg GRAPHIC 4206
5 GRAPHIC tlogo1.jpg GRAPHIC 12101
6 GRAPHIC tlogo2.jpg GRAPHIC 8179
7 GRAPHIC tpg10.jpg GRAPHIC 57318
8 GRAPHIC tpg12i.jpg GRAPHIC 69427
9 GRAPHIC tpg12ii.jpg GRAPHIC 80452
10 GRAPHIC tpg14.jpg GRAPHIC 13802
11 GRAPHIC tpg18a.jpg GRAPHIC 41393
12 GRAPHIC tpg18b.jpg GRAPHIC 35806
13 GRAPHIC tpg3.jpg GRAPHIC 22114
14 GRAPHIC tpg4.jpg GRAPHIC 44916
15 GRAPHIC tpg40a.jpg GRAPHIC 38658
16 GRAPHIC tpg40b.jpg GRAPHIC 41915
17 GRAPHIC tpg48.jpg GRAPHIC 81005
18 GRAPHIC tpg9.jpg GRAPHIC 20975
19 GRAPHIC tpgpx14.jpg GRAPHIC 27559
20 GRAPHIC tpgpx17.jpg GRAPHIC 65475
21 GRAPHIC tpgpx38.jpg GRAPHIC 23804
  Complete submission text file 0001144204-13-017126.txt   5697275
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 13713045
SIC: 2834 Pharmaceutical Preparations